[HTML][HTML] Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and CFTR Stop Mutations

…, Y Yaacov, H Blau, L Bentur, J Rivlin… - … England Journal of …, 2003 - Mass Medical Soc
Background Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR)
gene containing a premature termination signal cause a deficiency or absence of functional …

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

…, M Cohen, M Nissim-Rafinia, H Blau, J Rivlin… - The Lancet, 2008 - thelancet.com
Background In about 10% of patients worldwide and more than 50% of patients in Israel, cystic
fibrosis results from nonsense mutations (premature stop codons) in the messenger RNA (…

Upper airway morphology in patients with idiopathic obstructive sleep apnea

J Rivlin, V Hoffstein, J Kalbfleisch… - American Review of …, 1984 - atsjournals.org
Fundamental to the pathogenesis of obstructive sleep apnea (OSA) is the interaction of
physiologic and anatomic alterations of the upper airway. However, many patients with OSA …

[PDF][PDF] Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia

…, M Innes, B Kerem, MJ Nowaczyk, J Rivlin… - The American Journal of …, 2006 - cell.com
Mutations in FOXP2 cause developmental verbal dyspraxia (DVD), but only a few cases
have been described. We characterize 13 patients with DVD—5 with hemizygous paternal …

A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations

…, C FAMINI, H BLAU, J RIVLIN… - American journal of …, 2000 - atsjournals.org
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
containing a premature termination signal are expected to produce little or no CFTR chloride …

[HTML][HTML] Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel

…, H Blau, L Bentur, M Aviram, J Rivlin… - Emerging infectious …, 2008 - ncbi.nlm.nih.gov
This 2-year cross-sectional evaluation of nontuberculous mycobacterial (NTM) infections
involved all Israeli medical centers that treat cystic fibrosis patients. The study comprised 186 …

Clinical and genetic risk factors for cystic fibrosis-related liver disease

M Wilschanski, J Rivlin, S Cohen, A Augarten… - …, 1999 - publications.aap.org
Objective. The aim of this study was to define the role of possible risk factors for the development
of cystic fibrosis (CF)-related liver disease and to analyze the association between liver …

Mutation of serine/threonine protein kinase 36 (STK36) causes primary ciliary dyskinesia with a central pair defect

…, GW Dougherty, NT Loges, H Olbrich, J Rivlin… - Human …, 2017 - Wiley Online Library
Primary ciliary dyskinesia (PCD) is a genetic condition of impaired ciliary beating, characterized
by chronic infections of the upper and lower airways and progressive lung failure. …

Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients

…, L Bentur, H Blau, E Picard, J Rivlin… - Pediatric …, 2001 - Wiley Online Library
Lung transplantation (Tx) is an optional treatment for cystic fibrosis (CF) patients with end‐stage
lung disease. The decision to place a patient on the Tx waiting list is frequently complex, …

Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis

F Hakim, E Kerem, J Rivlin, L Bentur… - Journal of pediatric …, 2007 - journals.lww.com
Background: Increased levels of oxidative stress result in pulmonary damage contributing to
the development of chronic lung disease in cystic fibrosis (CF). The aim of this study was to …